go-v.orgcodex
Menu
Page tools

codex · Chemistry

Vaniprevir

Diagram for Vaniprevir
Vaniprevir (MK-7009) is a macrocyclic hepatitis C virus (HCV) NS3/4A protease inhibitor, developed by Merck & Co., which is currently in clinical testing. In Japan, it was approved for treating hepatitis C in 2014 under the brand name Vanihep. · image: Wikimedia Commons

Vaniprevir (MK-7009) is a macrocyclic hepatitis C virus (HCV) NS3/4A protease inhibitor, developed by Merck & Co., which is currently in clinical testing. In Japan, it was approved for treating hepatitis C in 2014 under the brand name Vanihep.

Wikipedia contributors, "Vaniprevir", Wikipedia, revision 1330639451, retrieved 20 November 2026, source, CC BY-SA 4.0.

More Chemistry · Search the codex